American College of Cardiology Annual Scientific Session

Healio brings you the highlights from the American College of Cardiology Annual Scientific Session. Refer back to this page often for the latest news from ACC, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting NewsPerspective

Combination rivaroxaban, aspirin reduces major adverse limb events in PAD

March 14, 2018
ORLANDO, Fla. — Patients with lower-extremity peripheral artery disease have a significantly worse prognosis after experiencing a major adverse…
Meeting NewsPerspective

STOP-PAD: Biologic therapy fails to improve outcomes in CLI

March 13, 2018
ORLANDO, Fla. — An experimental biologic treatment did not improve wound healing or major adverse limb event rates in patients with critical…
Meeting NewsPerspective

INDIE-HFpEF: Inhaled nitrate fails to improve quality of life, activity levels

March 13, 2018
ORLANDO, Fla. — Daily activity levels, peak exercise capacity, N-terminal pro-B-type natriuretic peptide and quality-of-life scores did not…
Meeting News

Pacemaker dependency common at 1 year after TAVR

March 13, 2018
ORLANDO, Fla. — About one-third of patients who underwent transcatheter aortic valve replacement were dependent on pacemakers at 30 days, with…
Meeting NewsPerspective

Hypertension intervention in barbershops cuts BP levels

March 12, 2018
ORLANDO, Fla. — Drug therapy in barbershops by specialty-trained pharmacists can be a useful intervention to target hypertension in the…
Meeting News

Febuxostat noninferior to allopurinol in patients with gout, major CV conditions

March 12, 2018
ORLANDO, Fla. — Febuxostat was noninferior to allopurinol in terms of adverse CV event rates in patients with gout and major CV coexisting…
Meeting News

Smartwatch technology can detect AF, hyperkalemia

March 12, 2018
ORLANDO, Fla. — An accessory and algorithm used in conjunction with a smartwatch accurately differentiated atrial fibrillation from sinus…
Meeting NewsPerspective

CANTOS: Canakinumab reduces CV events in CKD, diabetes

March 12, 2018
Canakinumab demonstrated efficacy in two patient groups with high CV risk and unmet medical need: those with chronic kidney disease and those with
Meeting News

Access to PCSK9 inhibitors challenging, but resources may help

March 12, 2018
ORLANDO, Fla. — Prescriptions for PCSK9 inhibitors are often denied by payers, but having access to the appropriate resources may help increase…
Meeting NewsPerspective

Dabigatran after noncardiac surgery reduces major CV complications in patients with myocardial injury

March 12, 2018
ORLANDO, Fla. — Treatment with dabigatran significantly reduced the risk for death, MI, stroke and other CV complications among patients with